Les thérapies ciblées per os

Lack of selectivity associated with a low therapeutic index of cytotoxic drugs together with improved knowledge of the carcinogenesis mechanisms have led to the development of a new therapeutic strategy for cancer which is more targeted and theoretically less toxic. Anticancer targeted therapies can kill cancer cells more selectively by interfering with specific protein or process involved in cancer growth. These treatments have considerably improved survival and quality of life of patients, most of them being self-administered at home.